Comparator: celecoxib
Sponsors
Organon and Co
Conditions
Osteoarthritis
Phase 3
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)
CompletedNCT00092768
Start: 2004-03-01End: 2005-02-01Updated: 2024-08-15
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)
CompletedNCT00092781
Start: 2004-03-01End: 2005-02-01Updated: 2024-08-15